BPG is committed to discovery and dissemination of knowledge
Articles in Press
9/29/2025 6:14:02 AM | Browse: 252 | Download: 20
Publication Name World Journal of Diabetes
Manuscript ID 109919
Country China
Category Urology & Nephrology
Manuscript Type Retrospective Study
Article Title Correlation of gut microbiota metabolite trimethylamine N-oxide with inflammatory levels and osteoporosis in patients with diabetic nephropathy
Manuscript Source Unsolicited Manuscript
All Author List Zhang-Lei Pan, Ming-Qiang Li, Jing Zhang, Ling-Yu Xue and Yan-Ping Shi
Funding Agency and Grant Number
Corresponding Author Yan-Ping Shi, Department of Nephrology, The Second Affiliated Hospital of Shandong First Medical University, Tai’an 271000, Shandong Province, China. shiyanping1823@126.com
Key Words Diabetic nephropathy; Gut microbiota; Trimethylamine N-oxide; Inflammatory cytokines; Osteoporosis
Core Tip In recent years, with in-depth research on the gut microbiota and the emergence of concepts such as the "gut-kidney axis" and the "intestinal-bone axis", the key role of the gut microbiota and its metabolites in metabolic disorders, inflammatory responses, and target organ damage has been increasingly recognized. Trimethylamine N-oxide (TMAO) is the main metabolite produced by the gut microbiota from dietary nutrients such as phosphatidylcholine and choline, and has attracted attention due to its participation in the pathogenesis of diabetic nephropathy (DN). In this study, we aim to explore the correlation between TMAO levels and the levels of inflammatory markers and osteoporosis (OP) in patients with DN, providing a theoretical and practical basis for the early identification of high-risk patients and timely clinical intervention. The research results confirm that elevated TMAO levels may mediate the inflammatory response and bone metabolism disorder in patients with DN, thereby promoting the progression of systemic inflammation and OP.
Citation Pan ZL, Li MQ, Zhang J, Xue LY, Shi YP. Correlation of gut microbiota metabolite trimethylamine N-oxide with inflammatory levels and osteoporosis in patients with diabetic nephropathy. World J Diabetes 2025; In press
Received
2025-06-17 09:37
Peer-Review Started
2025-06-23 00:32
To Make the First Decision
Return for Revision
2025-07-22 08:23
Revised
2025-07-31 04:30
Second Decision
2025-09-22 02:47
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-09-29 06:14
Articles in Press
2025-09-29 06:14
Publication Fee Transferred
2025-08-01 12:03
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com